ArticleBMC cancer2017

Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo.

M Buchholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.